| A36 | A new, globally appropriate rapid vaccine production platform: killed whole cell genome-reduced bacterial vaccine with surface-expressed antigen: applications to coronavirus and HIV fusion peptides | E-poster | Novel vectors and strategies |
| A41 | T cell maturation and senescence evolution after HCV elimination in HIV-HCV patients | E-poster | Co-infection: Viral hepatitis |
| A41 | Epidemiological history of hepatitis B virus in Portugal and the Portuguese role in its spreading across the world | E-poster | Co-infection: Viral hepatitis |
| A42 | High prevalence of bacterial sexually transmitted infections among Brazilian adolescents' men who have sex with men in Northeast Brazil | E-poster | Co-infection: STIs, including HPV |
| A42 | Bacterial STI rates by pharyngeal, urethral and rectal sites among adolescents' men who have sex with men in Northeast Brazil: the importance of comprehensive sample collection sites | E-poster | Co-infection: STIs, including HPV |
| A43 | Systematic review: COVID-19 and HIV, risk of hospitalization/ICU admission and mortality | E-poster | Co-infection: SARS-Co-V2 |
| A43 | Sars-COV-2 and HIV in Brazil: a dangerous combination | E-poster | Co-infection: SARS-Co-V2 |
| A45 | Overt expression of IL-32 isoforms in the colon of ART-treated PLWH: negative regulation by IL-17A | E-poster | Co-morbidities: Non-communicable diseases |
| A45 | Baricitinib reduces macrophage-mediated inflammation in HIV infection | E-poster | Co-morbidities: Non-communicable diseases |
| A45 | BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region | E-poster | Co-morbidities: Non-communicable diseases |